Vancomycin Levels After Joint Surgery
Author Information
Author(s): R Stauss, P Savov, GH Seeber, S Brand, M Ettinger, JA Beheshty
Primary Institution: Carl von Ossietzky Universität Oldenburg
Hypothesis
The topical application of vancomycin powder would not result in systemic vancomycin levels within the therapeutic range.
Conclusion
Intraarticular administration of vancomycin powder did not result in systemic vancomycin levels within the therapeutic range, indicating it may be a safe adjunct for preventing periprosthetic joint infection.
Supporting Evidence
- No systemic vancomycin levels within the therapeutic range were detected.
- Mean serum vancomycin levels were significantly higher in the THA cohort compared to TKA.
- The overall PJI rate was 0.0% at a mean follow-up of 5–6 months.
Takeaway
Doctors used a special powder during joint surgery to help prevent infections, and it didn't show harmful levels in the patients' blood.
Methodology
This was a prospective pilot study measuring serum vancomycin levels at 24 and 48 hours post-surgery in patients receiving intraarticular vancomycin powder.
Limitations
The study had a small sample size and limited follow-up duration of 6 months.
Participant Demographics
64% female, mean age 68.5 years.
Statistical Information
P-Value
p<0.001 for 24h, p=0.044 for 48h
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website